The awards program recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities. Gleeson was selected as a finalist by a panel of independent judges. Award winners will be announced at a special gala event on June 7, 2018 at the Fairmont Grand Del Mar.
Tim has been placed on an exclusive shortlist of San Diego-based CEOs who show exceptional leadership in their work and hold admiration from their respective teams.
Novasyte is excited to announce that Tim Gleeson, Chairman and CEO, has been selected as a semi-finalist in the Ernst & Young Entrepreneur Of The Year 2018 San Diego Regional Awards program.
Novasyte is thrilled to announce the appointment of Todd Schaefer to Senior Vice President of Sales and Marketing. Todd officially joined Novasyte on Monday, April 9, 2018 and is the first to hold this position.
He will be responsible for managing the sales, marketing, pharma and recall departments within Novasyte. Additionally, he will be a part of Senior Leadership Team and will contribute to the development and execution of Novasyte’s strategic goals.
Novasyte has announced the creation and appointment of two corporate positions. Ryan Jones, formerly VP of Sales, now holds the title of VP of Pharma Services and Hillary Medina, formerly Senior Director of Recall Services, now acts as VP of Field and Recall Services. Both positions were effective on Monday, April 9, 2018.
Organizations who have previously struggled with managing a recall internally, or perhaps do not have the time or resources to maintain the consignee data, develop a field strategy or create a centralized database, can trust Novasyte as their recall management partner.
Topics: White Paper, Industry Advancements, Industry Trends, Med-Tech Industry Update, Medical Device Industry, Medical Device Recall, Medical Device Field Action, S.M.A.R.T Programs, SMART recall program
It is easy to fall into the rhythm of receiving multiple spreadsheets from various sources – be it sales, regulatory, marketing or quality – and by having them in one place, feeling like the recall is “under control.” In working with more than half of the largest med-tech companies globally, Novasyte has discovered this is a common theme.
Despite the commonality of this approach, there are inherent associated risks with managing a recall across multiple spreadsheets. Here are the top four.
Topics: White Paper, SMART recall program, S.M.A.R.T Programs, Industry Advancements, Industry Trends, Med-Tech Industry Update, Medical Device Field Action, Medical Device Recall, Medical Device Industry
Prior to launching a field team to address the product need, it is critically important to assess the effectiveness of the field strategy as it could result in a significant, potentially unnecessary, budgetary hit.
Topics: White Paper, Industry Advancements, Industry Trends, Med-Tech Industry Update, Medical Device Field Action, Medical Device Industry, Medical Device Recall, SMART recall program, S.M.A.R.T Programs
This is never as simple as it sounds, and it may even sound obvious. That said, it is one of the critically important steps to ensuring a recall is executed accurately and timely.
Product recalls happen. Even to the most diligent organizations.
With the medical device landscape continually evolving, organizations must be agile and ready to respond to a recall at any moment. In looking at the annual number of medical device recalls in the graph below, one thing is known - recalls are not going away.
Topics: White Paper, SMART recall program, S.M.A.R.T Programs, Medical Device Recall, Medical Device Field Action, Medical Device Industry, Med-Tech Industry Update, Industry Trends, Industry Advancements